Apellis Pharmaceuticals (APLS) Buy Rating Reiterated at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for Apellis Pharmaceuticals in a note issued to investors on Thursday, July 13th. Zacks Research analyst A. Chakraborty now forecasts that the company will post earnings of $0.41 per share for the quarter, up from their […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) shares gapped down before the market opened on Tuesday . The stock had previously closed at $88.11, but opened at $82.50. Apellis Pharmaceuticals shares last traded at $84.71, with a volume of 597,729 shares. Analyst Upgrades and Downgrades Several equities research analysts recently weighed in on APLS shares. […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) had its target price boosted by Citigroup from $88.00 to $106.00 in a report published on Monday morning, The Fly reports. Several other research firms have also commented on APLS. HC Wainwright increased their price target on shares of Apellis Pharmaceuticals from $87.00 to $100.00 in a research report […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) had its price target raised by Bank of America from $112.00 to $114.00 in a report published on Friday, The Fly reports. APLS has been the topic of several other research reports. HC Wainwright boosted their price objective on Apellis Pharmaceuticals from $87.00 to $100.00 in a report on […]